171 related articles for article (PubMed ID: 19369534)
21. Could antiseptic mouthwash inhibit pharyngeal
Chow EPF; Fairley CK
Sex Transm Infect; 2017 Sep; 93(6):403. PubMed ID: 28827305
[No Abstract] [Full Text] [Related]
22. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Harry TC
Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
[No Abstract] [Full Text] [Related]
23. Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone.
Christophersen J; Bollerup AC; From E; Rønne-Rasmussen JO; Quitzau K
Genitourin Med; 1989 Jan; 65(1):14-7. PubMed ID: 2921047
[TBL] [Abstract][Full Text] [Related]
24. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
[TBL] [Abstract][Full Text] [Related]
25. The challenges of detecting gonorrhoea and chlamydia in rectal and pharyngeal sites: could we, should we, be doing more?
Alexander S
Sex Transm Infect; 2009 Jun; 85(3):159-60. PubMed ID: 19478103
[No Abstract] [Full Text] [Related]
26. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
[TBL] [Abstract][Full Text] [Related]
27. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Zhao L; Liu A; Li R; Zhao S
Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
[TBL] [Abstract][Full Text] [Related]
28. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
Unemo M
BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
[TBL] [Abstract][Full Text] [Related]
29. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.
Unemo M; Golparian D; Syversen G; Vestrheim DF; Moi H
Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144442
[TBL] [Abstract][Full Text] [Related]
30. Testing for pharyngeal gonorrhoea in heterosexual men: should we revisit national guidelines?
Dresser M; Hussey J
Int J STD AIDS; 2020 May; 31(6):593-595. PubMed ID: 32295478
[No Abstract] [Full Text] [Related]
31. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Manavi K; Young H; McMillan A
Int J STD AIDS; 2005 Jan; 16(1):68-70. PubMed ID: 15705277
[TBL] [Abstract][Full Text] [Related]
32. Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
Taylor SN; Marrazzo J; Batteiger BE; Hook EW; Seña AC; Long J; Wierzbicki MR; Kwak H; Johnson SM; Lawrence K; Mueller J
N Engl J Med; 2018 Nov; 379(19):1835-1845. PubMed ID: 30403954
[TBL] [Abstract][Full Text] [Related]
33. Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales.
Town K; Obi C; Quaye N; Chisholm S; Hughes G;
Sex Transm Infect; 2017 Feb; 93(1):39-45. PubMed ID: 27382010
[TBL] [Abstract][Full Text] [Related]
34. Multidrug-resistant
Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
[TBL] [Abstract][Full Text] [Related]
35. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
36. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.
Smith BL; Mogabgab WJ; Dalu ZA; Jones RB; Douglas JM; Handsfield HH; Hook EW; Viner BL; Shands JW; McCormack WM
Am J Med; 1993 Mar; 94(3A):81S-84S. PubMed ID: 8452187
[TBL] [Abstract][Full Text] [Related]
37. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Who Have Sex With Men: Diagnostic Accuracy of Nucleic Acid Amplification Test on Pooled Urine, Anorectal, and Pharyngeal Specimens.
Thielemans E; Wyndham-Thomas C; Henrard S; De Vleeschouwer A; Steensels D; Montesinos I; Debaisieux L; Delforge ML; Van Vooren JP; Goffard JC
Sex Transm Dis; 2018 Mar; 45(3):195-198. PubMed ID: 29419710
[TBL] [Abstract][Full Text] [Related]
38. Gonorrhea: Data on antibiotic resistance and accompanying infections at the University Hospital Dresden over a 10-year time period.
Abraham S; Poehlmann C; Spornraft-Ragaller P
J Dtsch Dermatol Ges; 2013 Mar; 11(3):241-9. PubMed ID: 23194411
[TBL] [Abstract][Full Text] [Related]
39. Pharyngeal Chlamydia and gonorrhea: a hidden problem.
Gaspari V; Marangoni A; D'Antuono A; Roncarati G; Salvo M; Foschi C; Re MC
Int J STD AIDS; 2019 Jul; 30(8):732-738. PubMed ID: 31046619
[No Abstract] [Full Text] [Related]
40. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men.
Handsfield HH; Murphy VL
Lancet; 1983 Jul; 2(8341):67-70. PubMed ID: 6134959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
